In his role as VP Commercial Strategy Asia Pacific, David is responsible for helping clients optimise their Veeva investment. He brings over 20 years experience consulting and working in the Life Sciences industry.
Before joining Veeva, David was the founder and managing director of Vedere Group, an organisation focusing on strategic sales & marketing, CRM solutions, commercial effectiveness, and performance management dashboards and reporting. After Vedere Group was acquired by IMS in 2013, David headed up the IMS Health Commercial Effectiveness and Technology & Services team for ANZ and Asia Pacific.
Prior to starting his own company, David was Global Head of Commercial Excellence for Boehringer Ingelheim, responsible for Product Launch Excellence, Sales & Marketing Performance Reporting & KPIs, Customer Segmentation & Targeting initiatives and Global CRM Implementation.